Cafepharma Today

May 27 2025 - Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Rocket crashes as gene therapy patient dies, FDA imposes hold
Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics
Trump taps Oz to lead drug pricing negotiations as customs warns against import violations
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Looking for a Pullback to Pick Up Johnson & Johnson's Shares
Seeking Alpha
Monday, July 11, 2011 - 9:51am
tags:
JNJ
Sanofi-Genzyme MS Drug: Mixed Results
TheStreet.com
Monday, July 11, 2011 - 9:50am
tags:
MS, multiple sclerosis, Sanofi, Genzyme
Teva settles with Merck over cholesterol drugs
Globes, Israel
Sunday, July 10, 2011 - 11:44am
tags:
Teva Pharmaceuticals, Merck, Vytorin, Zetia
Teva faces 2 key court hearings on Monday
Globes, Israel
Sunday, July 10, 2011 - 11:42am
tags:
Teva Pharmaceuticals, Pfizer, Mylan, Lipitor, Copaxone, legal
Wockhardt gets tentative USFDA nod for anti-depression drug
MoneyControl, India
Sunday, July 10, 2011 - 11:40am
tags:
Wockhardt, Cymbalta, Eli Lilly
Pfizer gets $800m boost for Lipitor
Financial Times, UK
Sunday, July 10, 2011 - 11:36am
tags:
Pfizer, Lipitor, cholesterol
Lilly’s Cialis Seeks to Surpass Pfizer’s Viagra, WiWo Reports
Bloomberg
Sunday, July 10, 2011 - 11:35am
tags:
Eli Lilly, Cialis, Viagra, erectile dysfunction, Pfizer
The Next Big Thing In Biotech: Transcept (video)
The Street
Sunday, July 10, 2011 - 11:33am
tags:
Transcept, Intermezzo, sleep aid, insomnia, Ambien
Amylin to Resubmit Diabetes Treatment to F.D.A.
NY Times
Sunday, July 10, 2011 - 11:28am
tags:
Amylin, Bydureon, diabetes, Eli Lilly, Alkermes
Exenatide tQT Study Showed No Prolongation of QT Interval
Pipeline Review
Saturday, July 9, 2011 - 12:43pm
tags:
exenatide, Eli Lilly, diabetes, Byetta, Amylin, Alkermes, Bydureon
Let's Just Hope For No More FDA Surprises
Motley Fool
Saturday, July 9, 2011 - 12:39pm
tags:
FDA, Amylin, Eli Lilly, Alkermes, Novo Nordisk
Bayer Loses Patent Protection For Contraceptive Yasmin In Europe
Fox Business
Saturday, July 9, 2011 - 12:37pm
tags:
Yasmin, Bayer
Pfizer Pulls Back on Radical Transformation
Seeking Alpha
Saturday, July 9, 2011 - 12:35pm
tags:
Pfizer
Lilly Chief Scolds Germany for New Pharma Rules
Motley Fool
Saturday, July 9, 2011 - 12:34pm
tags:
Eli Lilly
GlaxoSmithKline Receives FDA Approval for BOOSTRIX® to Help Prevent Whooping Cough in Adults 65 Years and Older
Yahoo/PR NewsWire
Saturday, July 9, 2011 - 12:33pm
tags:
GSK, Boostrix, whooping cough
Half a Breakup Is Better Than No Breakup at All
Motley Fool
Saturday, July 9, 2011 - 12:32pm
tags:
Pfizer
J&J’s Scios Unit Charged in Misbranding of Natrecor Drug
Bloomberg
Saturday, July 9, 2011 - 11:40am
tags:
JNJ, Natrecor
J&J Suppressed Oral Presention Cancer Test Over Listerine Link, Suit Says
Bloomberg
Saturday, July 9, 2011 - 11:39am
tags:
JNJ, Listerine
Teva Won’t Sell Generic Vytorin Until 2017 Under Accord
Bloomberg
Saturday, July 9, 2011 - 11:22am
tags:
Teva Pharmaceuticals, Vytorin
Is Forest Labs' Stock Cheap?
Motley Fool
Saturday, July 9, 2011 - 11:21am
tags:
Forest Labs

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.